NASDAQ:AIMD Ainos (AIMD) Stock Price, News & Analysis → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free AIMD Stock Alerts $1.04 0.00 (0.00%) (As of 04:26 PM ET) Add Compare Share Share Today's Range$1.04▼$1.0650-Day Range$1.01▼$2.0552-Week Range$0.79▼$6.10Volume11,628 shsAverage Volume1.26 million shsMarket Capitalization$6.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Get Ainos alerts: Email Address Ad Huge AlertsWhy Is Gold On a MASSIVE rally? Gold has been on a tear this year. The yellow metal has hit an all-time high of $2,4231.29 recently and the rally could be far from over. From central banks to even Costco customers, it seems everyone is buying gold these days. With Wall Street watching the gold space carefully, now is a perfect time to pay attention to this stock.This Little known Company is a uniquely structured for profit About Ainos Stock (NASDAQ:AIMD)Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.Read More AIMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AIMD Stock News HeadlinesMay 13, 2024 | investorplace.comAIMD Stock Earnings: Ainos Reported Results for Q1 2024May 13, 2024 | finanznachrichten.deAinos, Inc.: Ainos Reports First Quarter 2024 Financial ResultsMay 11, 2024 | americanbankingnews.comReviewing Ainos (AIMD) & Its RivalsMay 7, 2024 | finanznachrichten.deAinos, Inc.: Ainos Raises $9 Million in Growth Capital with Existing ShareholderMarch 11, 2024 | msn.comTraders Anticipate Inflation Report as US Equities Open Lower on Wall StreetMarch 9, 2024 | benzinga.comAinos Stock (NASDAQ:AIMD), Quotes and News SummaryMarch 8, 2024 | investorplace.comWhy Is Ainos (AIMD) Stock Up 153% Today?March 4, 2024 | benzinga.comWhy Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day SessionMarch 4, 2024 | msn.comWhy BioVie Shares Are Trading Lower By Around 42%; Here Are 20 Stocks Moving PremarketMarch 4, 2024 | investorplace.comWhy Is Ainos (AIMD) Stock Up 57% Today?February 6, 2024 | msn.comAinos Announces FDA Progress on COVID-19 Treatment TrialJanuary 24, 2024 | msn.comAinos announces $1.75M follow-on fundingJanuary 24, 2024 | finanznachrichten.deAinos, Inc.: Ainos Announces $1.75 Million Follow-On FundingJanuary 24, 2024 | finance.yahoo.comAinos Announces $1.75 Million Follow-On FundingSee More Headlines Receive AIMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ainos and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/17/2024Next Earnings (Estimated)8/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:AIMD Previous SymbolNASDAQ:AIMD CUSIPN/A CIK1014763 Webwww.ainos.com Phone858-869-2986Fax806-376-9301Employees46Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,770,000.00 Net Margins-15,348.14% Pretax Margin-15,347.09% Return on Equity-55.38% Return on Assets-44.99% Debt Debt-to-Equity Ratio0.10 Current Ratio0.32 Quick Ratio1.72 Sales & Book Value Annual Sales$120,000.00 Price / Sales54.95 Cash FlowN/A Price / Cash FlowN/A Book Value$3.61 per share Price / Book0.29Miscellaneous Outstanding Shares6,280,000Free Float5,998,000Market Cap$6.59 million OptionableNot Optionable Beta1.47 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Chun-Hsien Tsai (Age 54)Chairman of Board, President & CEO Comp: $112.12kMr. Lawrence Kennedy Lin (Age 55)Executive Vice President of Operations Comp: $144kMr. Hsin-Liang Lee (Age 53)Chief Financial Officer Mr. Chih-Heng Lu (Age 44)Director of Corporate Developoment Key CompetitorsHillstream BioPharmaNASDAQ:HILSHepion PharmaceuticalsNASDAQ:HEPAASLAN PharmaceuticalsNASDAQ:ASLNProtagenic TherapeuticsNASDAQ:PTIXBiofronteraNASDAQ:BFRIView All Competitors AIMD Stock Analysis - Frequently Asked Questions How have AIMD shares performed in 2024? Ainos' stock was trading at $2.05 at the beginning of 2024. Since then, AIMD stock has decreased by 48.8% and is now trading at $1.05. View the best growth stocks for 2024 here. When is Ainos' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, August 9th 2024. View our AIMD earnings forecast. When did Ainos' stock split? Ainos's stock reverse split on the morning of Thursday, December 14th 2023. The 1-5 reverse split was announced on Thursday, December 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split. When did Ainos IPO? Ainos (AIMD) raised $3 million in an initial public offering on Tuesday, August 9th 2022. The company issued 800,000 shares at a price of $4.25 per share. Maxim Group acted as the underwriter for the IPO and Brookline Capital Markets was co-manager. How do I buy shares of Ainos? Shares of AIMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:AIMD) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDems have chosen Biden replacement?Paradigm PressDoes this make you sick?Allegiance GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldA ‘DeFi Summer’ Projected!Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.